Pharmacological properties of Salvia officinalis and its components

Journal of Traditional and Complementary Medicine

Volumn 7, Issue 4, 2017, Pages 433-440

  Ghorbani, Ahmad ^a   Esmaeilizadeh, Mahdi ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ESFARAYEN FACULTY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticancer; Antimutagenic; Flavonoids; Sage; Salvia officinalis

Indexed keywords

EID: 85009784455     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2016.12.014     Document Type: Article

References (108)

1. Bisset, N.G., Wichtl, M., Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis with Reference to German Commision E Monographs. 2nd ed., 2001, CRC Press, Boca Raton, FI, 440–443.
2. Miura, K., Kikuzaki, H., Nakatani, N., Apianane terpenoids from Salvia officinalis. Phytochemistry 58 (2001), 1171–1175.
3. Physicians' Desk Reference (PDR) for Herbal Medicines, 3rd ed., 2004, Thompson, Montvale, NJ, 698–701.
4. Zargari, A., Medicinal Plants. 4th ed., 1990, Tehran University Press, Tehran, 59–64.
5. Garcia, C.S.C., Menti, C., Lambert, A.P.F., et al. Pharmacological perspectives from Brazilian Salvia officinalis (Lamiaceae): antioxidant, and antitumor in mammalian cells. An Acad Bras Ciênc 88 (2016), 281–292.
6. Perry, E.K., Pickering, A.T., Wang, W.W., Houghton, P.J., Perry, N.S., Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J Pharm Pharmacol 51 (1999), 527–534.
7. Adams, M., Gmünder, F., Hamburger, M., Plants traditionally used in age related brain disorders–a survey of ethnobotanical literature. J Ethnopharmacol 113 (2007), 363–381.
8. European Medicines Agency, Community Herbal Monograph on Salvia officinalis L., Folium. 2009, European Medicines Agency, London.
9. Badiee, P., Nasirzadeh, A.R., Motaffaf, M., Comparison of Salvia officinalis L. essential oil and antifungal agents against candida species. J Pharm Technol Drug Res, 1, 2012, 7.
10. Capek, P., Hríbalová, V., Water-soluble polysaccharides from Salvia officinalis L. possessing immunomodulatory activity. Phytochemistry 65 (2004), 1983–1992.
11. El Hadri, A., del Río, M.Á.G., Sanz, J., et al. Cytotoxic activity of α-humulene and transcaryophyllene from Salvia officinalis in animal and human tumor cells. An R Acad Nac Farm 76 (2010), 343–356.
12. Hayouni, E.A., Chraief, I., Abedrabba, M., et al. Tunisian Salvia officinalis L. and Schinusmolle L. essential oils: their chemical compositions and their preservative effects against Salmonella inoculated in minced beef meat. Int J Food Microbiol 125 (2008), 242–251.
13. Langer, R., Mechtler, C., Jurenitsch, J., Composition of the essential oils of commercial samples of Salvia officinalis L. and S. fruticosa Miller: a comparison of oils obtained by extraction and steam distillation. Phytochem Anal 7 (1996), 289–293.
14. Lima, C.F., Carvalho, F., Fernandes, E., et al. Evaluation of toxic/protective effects of the essential oil of Salvia officinalis on freshly isolated rat hepatocytes. Toxicol In Vitro 18 (2004), 457–465.
15. Lima, C.F., Andrade, P.B., Seabra, R.M., Fernandes-Ferreira, M., Pereira-Wilson, C., The drinking of a Salvia officinalis infusion improves liver antioxidant status in mice and rats. J Ethnopharmacol 97 (2005), 383–389.
16. 4-induced hepatotoxicity in mice. Food Chem Toxicol 45 (2007), 456–464.
17. Lima, C.F., Valentao, P.C.R., Andrade, P.B., Seabra, R.M., Fernandes-Ferreira, M., Pereira-Wilson, C., Water and methanolic extracts of Salvia officinalis protect HepG2 cells from t-BHP induced oxidative damage. Chem Biol Interact 167 (2007), 107–115.
18. Lu, Y., Foo, L.Y., Flavonoid and phenolic glycosides from Salvia officinalis. Phytochemistry 55 (2000), 263–267.
19. Mitic-Culafic, D., Vukovic-Gacic, B., Knezevic-Vukcevic, J., Stankovic, S., Simic, D., Comparative study on the antibacterial activity of volatiles from sage (Salvia officinalis L.). Arch Biol Sci 57 (2005), 173–178.
20. Russo, A., Formisano, C., Rigano, D., et al. Chemical composition and anticancer activity of essential oils of Mediterranean sage (Salvia officinalis L.) grown in different environmental conditions. Food Chem Toxicol 55 (2013), 42–47.
21. Seidel, V., Initial and bulk extraction. Sarker, S.D., Latif, Z., Gray, A.I., (eds.) Natural Product Isolation, 2006, Humana Press, New Jersey, NY, 27–46.
22. Veličković, D.T., Ranđelović, N.V., Ristić, M.S., Veličković, A.S., Šmelcerović, A.A., Chemical constituents and antimicrobial activity of the ethanol extracts obtained from the flower, leaf and stem of Salvia officinalis L. J Serb Chem Soc 68 (2003), 17–24.
23. Venskutonis, P.R., Effect of drying on the volatile constituents of thyme (Thymus vulgaris L.) and sage (Salvia oficinalis L.). Food Chem 59 (1997), 219–227.
24. Wang, M., Li, J., Rangarajan, M., et al. Antioxidative phenolic compounds from Sage (Salvia officinalis). J Agric Food Chem 46 (1998), 4869–4873.
25. Wang, M., Kikuzaki, H., Zhu, N., Sang, S., Nakatani, N., Ho, C.T., Isolation and structural elucidation of two new glycosides from sage (Salvia officinalis L.). J Agric Food Chem 48 (2000), 235–238.
26. Hernandez-Saavedra, D., Perez-Ramirez, I.F., Ramos-Gomez, M., Mendoza-Diaz, S., Loarca-Pina, G., Reynoso-Camacho, R., Phytochemical characterization and effect of Calendula officinalis, Hypericum perforatum, and Salvia officinalis infusions on obesity associated cardiovascular risk. Med Chem Res 25 (2016), 163–172.
27. Pedro, D.F., Ramos, A.A., Lima, C.F., Baltazar, F., Pereira-Wilson, C., Colon cancer chemoprevention by sage tea drinking: decreased DNA damage and cell proliferation. Phytother Res 30 (2016), 298–305.
28. Jedinák, A., Mucková, M., Kost'álová, D., Maliar, T., Masterova, I., Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis. Z Natur forsch 61 (2006), 777–782.
29. Sertel, S., Eichhorn, T., Plinkert, P.K., Efferth, T., Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1). HNO 59 (2011), 1203–1208.
30. Xavier, C.P., Lima, C.F., Fernandes-Ferreira, M., Pereira-Wilson, C., Salvia fruticosa, Salvia officinalis, and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: the role in MAPK/ERK pathway. Nutr Cancer 61 (2009), 564–571.
31. Kontogianni, V.G., Tomic, G., Nikolic, I., et al. Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem 136 (2013), 120–129.
32. Keshavarz, M., Mostafaie, A., Mansouri, K., Bidmeshkipour, A., Motlagh, H.R., Parvaneh, S., In vitro and ex vivo antiangiogenic activity of Salvia officinalis. Phytother Res 24 (2010), 1526–1531.
33. Keshavarz, M., Bidmeshkipour, A., Mostafaie, A., Mansouri, K., Mohammadi-Motlagh, H.R., Antitumor activity of Salvia officinalis is due to its anti-angiogenic, anti-migratory and anti-proliferative effects. Cell J 12 (2011), 477–482.
34. de Oliveira, P.F., Munari, C.C., Nicolella, H.D., Veneziani, R.C., Tavares, D.C., Manool, a Salvia officinalis diterpene, induces selective cytotoxicity in cancer cells. Cytotechnology 68 (2016), 2139–2143.
35. Jedinák, A., Mucková, M., Kost'álová, D., Maliar, T., Masterova, I., Antiprotease and antimetastatic activity of ursolic acid isolated from Salvia officinalis. Z Naturforsch C 61 (2006), 777–782.
36. Yesil-Celiktas, O., Sevimli, C., Bedir, E., Vardar-Sukan, F., Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr 65 (2010), 158–163.
37. Sharmila, R., Manoharan, S., Anti-tumor activity of rosmarinic acid in 7,12-dimethylbenz(a)anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. Indian J Exp Biol 50 (2012), 187–194.
38. Xu, Y., Jiang, Z., Ji, G., Liu, J., Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. Planta Med 76 (2010), 956–962.
39. Moon, D.O., Kim, M.O., Lee, J.D., Choi, Y.H., Kim, G.Y., Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells. Cancer Lett 288 (2010), 183–191.
40. Scheckel, K.A., Degner, S.C., Romagnolo, D.F., Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines. J Nutr 138 (2008), 2098–2105.
41. Huang, S.S., Zheng, R.L., Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 239 (2006), 271–280.
42. Vuković-Gačić, B., Nikčević, S., Berić-Bjedov, T., Knežević-Vukčević, J., Simić, D., Antimutagenic effect of essential oil of sage (Salvia officinalis L.) and its monoterpenes against UV-induced mutations in Escherichia coli and Saccharomyces cerevisiae. Food Chem Toxicol 44 (2006), 1730–1738.
43. Patenković, A., Stamenković-Radak, M., Banjanac, T., Andjelković, M., Antimutagenic effect of sage tea in the wing spot test of Drosophila melanogaster. Food Chem Toxicol 47 (2009), 180–183.
44. Alkan, F.U., Gürsel, F.E., Ateş, A., Özyürek, M., Güçlü, K., Altun, M., Protective effects of Salvia officinalis extract against cyclophosphamide-induced genotoxicity and oxidative stress in rats. Turk J Vet Anim Sci 36 (2012), 646–654.
45. Kozics, K., Klusová, V., Srančíková, A., et al. Effects of Salvia officinalis and Thymus vulgaris on oxidant-induced DNA damage and antioxidant status in HepG2 cells. Food Chem Toxicol 141 (2013), 2198–2206.
46. Vujošević, M., Blagojević, J., Antimutagenic effects of extracts from sage (Salvia officinalis) in mammalian system in vivo. Acta Vet Hung 52 (2004), 439–443.
47. Nikolić, B., Mitić-ćulafić, D., Vuković-Gačić, B., Knežević-Vukčevi, J., The antimutagenic effect of monoterpenes against UV-irradiation-, 4NQO- and T-BOOH-induced mutagenesis in coli. Arch Biol Sci Belgr 63 (2011), 117–128.
48. Simić, D., Vuković-Gačić, B., Knežević-Vukčević, J., Detection of natural bioantimutagens and their mechanisms of action with bacterial assay-system. Mutat Res 402 (1998), 51–57.
49. Carvalho, A.N., Firuzi, O., Gama, M.J., van Horssen, J., Saso, L., Oxidative stress and antioxidants in neurological diseases: is there still hope?. Curr Drug Targets, 2016 (in press), [Epub ahead of print].
50. Jha, J.C., Banal, C., Chow, B.S., Cooper, M.E., Jandeleit-Dahm, K., Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal 25 (2016), 657–684.
51. Li, H., Horke, S., Forstermann, U., Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol Sci 34 (2013), 313–319.
52. Toyokuni, S., Oxidative stress as an iceberg in carcinogenesis and cancer biology. Arch Biochem Biophys 595 (2016), 46–49.
53. Horváthová, E., Srančíková, A., Regendová-Sedláčková, E., et al. Enriching the drinking water of rats with extracts of Salvia officinalis and Thymus vulgaris increases their resistance to oxidative stress. Mutagenesis 31 (2016), 51–59.
54. Cuvelier, M.E., Richard, H., Berset, C., Antioxidative activity and phenolic composition of pilot-plant and commercial extracts of sage and rosemary. J Am Oil Chemists' Soc 73 (1996), 645–652.
55. Dianat, M., Esmaeiliziadeh, M., Badavi, M., Samarbafzadeh, A., Naghizadeh, B., Cardiac protective effects of crocin on hemodynamic parameters and infarct size in compare vitamin E after ischemia reperfusion in isolated rat heart. Planta Med 80 (2014), 393–398.
56. Miura, K., Kikuzaki, H., Nakatani, N., Antioxidant activity of chemical components from sage (Salvia officinalis L.) and thyme (Thymus vulgaris L.) measured by the oil stability index method. J Agric Food Chem 50 (2002), 1845–1851.
57. Govindaraj, J., Sorimuthu Pillai, S., Rosmarinic acid modulates the antioxidant status and protects pancreatic tissues from glucolipotoxicity mediated oxidative stress in high-fat diet: streptozotocin-induced diabetic rats. Mol Cell Biochem 404 (2015), 143–159.
58. Azevedo, M.I., Pereira, A.F., Nogueira, R.B., et al. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy. Mol Pain, 9, 2013, 53.
59. Sadeghnia, H.R., Yousefsani, B.S., Rashidfar, M., Boroushaki, M.T., Assadpour, E., Ghorbani, A., Protective effect of rutin on hexachlorobutadiene-induced nephrotoxicity. Ren Fail 35 (2013), 1151–1155.
60. Brune, K., Patrignani, P., New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res 8 (2015), 105–111.
61. Abad, N.A.A., Nouri, M.H.K., Tavakkoli, F., Effect of Salvia officinalis hydroalcoholic extract on vincristine-induced neuropathy in mice. Chin J Nat Med 9 (2011), 354–358.
62. Abad, M., Moreno, A., Palacios, A., Narita, M., Blanco, F., The tumor suppressor ING1 contributes to epigenetic control of cellular senescence. Aging Cell 10 (2011), 158–171.
63. Khayate-Nouri, M.H., Namvaran-Abbasabad, A., Tavakkoli, F., Salvia Officinalis and cisplatin effects on pentylenetetrazole induced seizure threshold print. Zahedan J Res Med Sci 15 (2013), 1–3.
64. Mansourabadi, A.M., Sadeghi, H.M., Razavi, N., Rezvani, E., Anti-inflammatory and analgesic properties of salvigenin, Salvia officinalis flavonoid extracted. Adv Herb Med 1 (2015), 31–41.
65. Nicolella, H., Senedese, J., Furtado, R., Veneziani, R., Tavares, D., Evaluation of anti-inflammatory potential of diterpene manool in macrophages by quantification of nitric oxide. J Int Soc Antioxid Nutr Health 1 (2015), 124–128.
66. Qnais, E.Y., Abu-Dieyeh, M., Abdulla, F.A., Abdalla, S.S., The antinociceptive and anti-inflammatory effects of Salvia officinalis leaf aqueous and butanol extracts. Pharm Biol 48 (2010), 1149–1156.
67. Rodrigues, M.R., Kanazawa, L.K., das Neves, T.L., et al. Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice. J Ethnopharmacol 139 (2012), 519–526.
68. Pra, V.D., Bisol, L.B., Detoni, S., Denti, M., Grando, J., Anti-inflammatory activity of fractionated extracts of Salvia officinalis. J Appl Pharm Sci 1 (2011), 67–71.
69. Schröder, S., Beckmann, K., Franconi, G., et al. Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?. Evid Based Complement Alternat Med, 2013, 2013, 423713.
70. Baricevic, D., Sosa, S., Della Loggia, R., et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol 75 (2001), 125–132.
71. Osakabe, N., Yasuda, A., Natsume, M., Yoshikawa, T., Rosmarinic acid inhibits epidermal inflammatory responses: anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 25 (2004), 549–557.
72. Hubbert, M., Sievers, H., Lehnfeld, R., Kehrl, W., Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis – a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. Eur J Med Res 11 (2006), 20–26.
73. Lalićević, S., Djordjević, I., Comparison of benzydamine hydrochloride and Salvia officinalis as an adjuvant local treatment to systemic nonsteroidal anti-inflammatory drug in controlling pain after tonsillectomy, adenoidectomy, or both: an open-label, single-blind, randomized clinical trial. Curr Ther Res Clin Exp 65 (2004), 360–372.
74. Bozin, B., Mimica-Dukic, N., Samojlik, I., Jovin, E., Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 55 (2007), 7879–7885.
75. Delamare, A.P.L., Moschen-Pistorello, I.T., Artico, L., Atti-Serafini, L., Echeverrigaray, S., Antibacterial activity of the essential oils of Salvia offcinalis L. and Salvia triloba L. cultivated in South Brazil. Food Chem 100 (2007), 603–608.
76. Akkawi, R., Valente, A.L., Badawy, S.Z., Large mesonephric cyst with acute adnexal torsion in a teenage girl. J Pediatr Adolesc Gynecol 25 (2012), e143–e145.
77. Tada, M., Okuno, K., Chiba, K., Ohnishi, E., Yoshii, T., Antiviral diterpens from Saliva officinialis. Phytochemistry 35 (1994), 539–541.
78. Carta, C., Moretti, M.D.L., Peana, A.T., Activity of the oil of Salvia officinalis L. against Botrytis cinerea. J Essent Oil Res 8 (1996), 399–404.
79. Horiuchi, K., Shiota, S., Hatano, T., Yoshida, T., Kuroda, T., Tsuchiya, T., Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci. Biol Pharm Bull 30 (2007), 1147–1149.
80. Horiuchi, K., Shiota, S., Kuroda, T., Hatano, T., Yoshida, T., Tsuchiya, T., Potentiation of antimicrobial activity of aminoglycosides by carnosol from Salvia officinalis. Biol Pharm Bull 30 (2007), 287–290.
81. Eidi, M., Eidi, A., Bahar, M., Effects of Salvia officinalis L. (sage) leaves on memory retention and its interaction with the cholinergic system in rats. Nutrition 22 (2006), 321–326.
82. Hasanein, P., Felehgari, Z., Emamjomeh, A., Preventive effects of Salvia officinalis L. against learning and memory deficit induced by diabetes in rats: possible hypoglycaemic and antioxidant mechanisms. Neurosci Lett 622 (2016), 72–77.
83. Gomar, A., Hosseini, A., Mirazi, N., Evaluation of Salvia officinalis L. (sage) leaves on morphine-induced memory impairment in adult male rats. Focus Altern Complement Ther 19 (2014), 156–162.
84. Miroddi, M., Navarra, M., Quattropani, M.C., Calapai, F., Gangemi, S., Calapai, G., Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease. CNS Neurosci Ther 20 (2014), 485–495.
85. Moss, L., Rouse, M., Wesnes, K.A., Moss, M., Differential effects of the aromas of Salvia species on memory and mood. Hum Psychopharmacol 25 (2010), 388–396.
86. Moss, M., Rouse, M., Moss, L., Aromas of salvia species enhance everyday prospective memory performance in healthy young adults. Adv Chem Eng Sci 4 (2014), 339–346.
87. Scholey, A.B., Tildesley, N.T., Ballard, C.G., et al. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology 198 (2008), 127–139.
88. Akhondzadeh, S., Noroozian, M., Mohammadi, M., Ohadinia, S., Jamshidi, A.H., Khani, M., Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28 (2003), 53–59.
89. Kennedy, D.O., Pace, S., Haskell, C., Okello, E.J., Milne, A., Scholey, A.B., Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology 31 (2006), 845–852.
90. Russo, P., Frustaci, A., Del Bufalo, A., Fini, M., Cesario, A., From traditional European medicine to discovery of new drug candidates for the treatment of dementia and Alzheimer's disease: acetylcholinesterase inhibitors. Curr Med Chem 20 (2013), 976–983.
91. Milne, E., White, S., Campbell, R., Swettenham, J., Hansen, P., Ramus, F., Motion and form coherence detection in autistic spectrum disorder: relationship to motor control and 2:4 digit ratio. J Autism Dev Disord 36 (2006), 225–237.
92. Ghorbani, A., Phytotherapy for diabetic dyslipidemia: evidence from clinical trials. Clin Lipidol 8 (2013), 311–319.
93. Ghorbani, A., Best herbs for managing diabetes: a review of clinical studies. Braz J Pharm Sci 49 (2013), 413–422.
94. Ghorbani, A., MoradiMarjaneh, R., Rajaei, Z., Hadjzadeh, M.A.R., Effects of Securigera securidaca extract on lipolysis and adipogenesis in diabetic rats. Cholestrol, 2014, 2014, 582106.
95. Behradmanesh, S., Derees, F., Rafieian-kopaei, M., Effect of Salvia officinalis on diabetic patients. J Ren Inj Prev 2 (2013), 51–54.
96. Eidi, M., Eidi, A., Zamanizadeh, H., Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J Ethnopharmacol 100 (2005), 310–313.
97. Eidi, M., Eidi, A., Antidiabetic effects of sage (Salvia officinalis L.) leaves in normal and streptozotocin-induced diabetic rats. Diabetes Metab Syndr Clin Res Rev 3 (2009), 40–44.
98. Khattab, H.A.H., Mohamed, R.A., Hashemi, J.M., Evaluation of hypoglycemic activity of Salvia officinalis L. (Sage) infusion on streptozotocin-induced diabetic rats. J Am Sci 8 (2012), 411–416.
99. Lima, C.F., Azevedo, M.F., Araujo, R., Fernandes-Ferreira, M., Pereira-Wilson, C., Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention?. Br J Nutr 96 (2006), 326–333.
100. Christensen, K.B., Jørgensen, M., Kotowska, D., Petersen, R.K., Kristiansen, K., Christensen, L.P., Activation of the nuclear receptor PPARγ by metabolites isolated from sage (Salvia officinalis L). J Ethnopharmacol 132 (2010), 127–133.
101. Shafiee-Nick, R., Ghorbani, A., Vafaee Bagheri, F., Rakhshandeh, H., Chronic administration of a combination of six herbs inhibits the progression of hyperglycemia and decreases serum lipids and aspartate amino transferase activity in diabetic rats. Adv Pharmacol Sci, 2012, 2012, 789796.
102. Kianbakht, S., Abasi, B., Perham, M., Hashem Dabaghian, F., Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial. Phytother Res 25 (2011), 1849–1853.
103. Kianbakht, S., Dabaghian, F.H., Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo controlled clinical trial. Complement Ther Med 21 (2013), 441–446.
104. Sá, C.M., Ramos, A.A., Azevedo, M.F., Lima, C.F., Fernandes-Ferreira, M., Pereira-Wilson, C., Sage tea drinking improves lipid profile and antioxidant defences in humans. Int J Mol Sci 10 (2009), 3937–3950.
105. Seo, S., Lee, M.S., Chang, E., et al. Rutin increases muscle mitochondrial biogenesis with AMPK activation in high-fat diet-induced obese rats. Nutrients 7 (2015), 8152–8169.
106. Mills, S., Bone, K., The Essential Guide to Herbal Safety. 2005, Elsevier, St Louis, Missouri, 558–559.
107. Halicioglu, O., Astarcioglu, G., Yaprak, I., Aydinlioglu, H., Toxicity of Salvia officinalis in a newborn and a child: an alarming report. Pediatr Neurol 45 (2011), 259–260.
108. Kavvadias, D., Monschein, V., Sand, P., Riederer, P., Schreier, P., Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor. Planta Med 69 (2003), 113–117.